Catalyst Wire Dossier Catalyst Wire Dossier

Sabirnetug

sabirnetug · Acumen Pharmaceuticals
Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for Sabirnetug, covering 2024-10-18 to 2025-10-27. Get the full timeline:

Most recent: Clinical Trial Update: A Study to Evaluate Efficacy and Safety of Intravenous Sabirnetug in Participants With Early Alzheimer's Disease (ALTITUDE-AD) [Phase 2]

See pricing